Vaccines: From valuation to resource allocation

被引：15

作者：

Bloom, David E. ^{[1
]}

Madhavan, Guruprasad ^{[2
]}

机构：

[1] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA

[2] Natl Acad Sci, Inst Med, Washington, DC 20418 USA

来源：

VACCINE | 2015年 / 33卷

关键词：

Resource allocation; Data collection; Strategic planning tools; VACCINATION; BENEFITS;

D O I：

10.1016/j.vaccine.2015.02.071

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This review focuses on selected challenges and opportunities concerning broader valuation of vaccines and immunization. The challenges involve conceptualizing and measuring the value of vaccines, while the opportunities relate to the strategic and systematic use of that information in health policy decisions that range from the adoption of particular vaccines in national immunization plans to the allocation of resources to vaccine research, development, and delivery. Clarifying the demonstrable individual, family, and community-level benefits of vaccines will allow the public health community to make better-informed and more meaningful comparisons of the costs of vaccines in relation to their full benefits. Taking advantage of this opportunity will require enhanced data collection and the development of strategic planning tools for transparently assessing trade-offs among the myriad attributes of different vaccines in various social and economic contexts. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：B52 / B54

页数：3

共 17 条

[1]

[Anonymous], 2014, Global immunization Data

[2]

[Anonymous], 2014, IMM COV

[3] Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus [J].

Baernighausen, T. ;

Bloom, D. E. ;

Cafiero, E. T. ;

O'Brien, J. C. .

CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 :70-76

[4] Valuing vaccination [J].

Baernighausen, Till ;

Bloom, David E. ;

Cafiero-Fonseca, Elizabeth T. ;

O'Brien, Jennifer Carroll .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (34) :12313-12319

[5] Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type b vaccine [J].

Baernighausen, Till ;

Bloom, David E. ;

Canning, David ;

Friedman, Abigail ;

Levine, Orin S. ;

O'Brien, Jennifer ;

Privor-Dumm, Lois ;

Walker, Damian .

VACCINE, 2011, 29 (13) :2371-2380

[6]

Bloom DE, 2011, APPL ECON, V44, P2777

[7]

Cernuschi T, 2011, PNEUMOCOCCAL ADV MAR

[8]

Doctors Without Borders, 2015, MSF CALLS GSK PFIZ S

[9]

Fallows J, 2013, THE ATLANTIC 1023

[10] Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020 [J].

Gandhi, Gian ;

Lydon, Patrick ;

Cornejo, Santiago ;

Brenzel, Logan ;

Wrobel, Sandra ;

Chang, Hugh .

VACCINE, 2013, 31 :B137-B148

← 1 2 →